These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1435104)

  • 1. Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression.
    Power AC; Cowen PJ
    Mol Aspects Med; 1992; 13(3):205-20. PubMed ID: 1435104
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.
    Hollander E; Kwon J; Weiller F; Cohen L; Stein DJ; DeCaria C; Liebowitz M; Simeon D
    Psychiatry Res; 1998 Jul; 79(3):213-7. PubMed ID: 9704868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroendocrine disturbances observed in obsessive compulsive disorders].
    Hantouche E; Olié JP
    Ann Med Psychol (Paris); 1992; 150(2-3):152-7. PubMed ID: 1343510
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA; DeMeo MD; Sweeney JA; Halper J; Mann JJ; Shear MK
    Biol Psychiatry; 1992 Jan; 31(1):19-34. PubMed ID: 1311964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT and human anxiety. Evidence from studies using acute tryptophan depletion.
    Anderson IM; Mortimore C
    Adv Exp Med Biol; 1999; 467():43-55. PubMed ID: 10721037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine findings in anxiety disorders.
    Curtis GC; Glitz DA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):131-48. PubMed ID: 3288472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCD: a disorder with anxiety, aggression, impulsivity, and depressed mood.
    Stein DJ; Hollander E; DeCaria C; Trungold S
    Psychiatry Res; 1991 Feb; 36(2):237-9. PubMed ID: 2017538
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin, the periaqueductal gray and panic.
    Graeff FG
    Neurosci Biobehav Rev; 2004 May; 28(3):239-59. PubMed ID: 15225969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotonin, periaqueductal gray matter and panic disorder].
    Graeff FG
    Braz J Psychiatry; 2003 Dec; 25 Suppl 2():42-5. PubMed ID: 14978586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
    Blier P; de Montigny C
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):91S-98S. PubMed ID: 10432494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC; Goodman WK; Price LH; McDougle CJ; Charney DS
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A receptor sensitivity in depression and anxiety disorders: molecular mechanisms of neuroadaption.
    Lesch KP; Aulakh CS; Murphy DL
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():208A-209A. PubMed ID: 1498813
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetically driven brain serotonin deficiency facilitates panic-like escape behavior in mice.
    Waider J; Popp S; Lange MD; Kern R; Kolter JF; Kobler J; Donner NC; Lowe KR; Malzbender JH; Brazell CJ; Arnold MR; Aboagye B; Schmitt-Böhrer A; Lowry CA; Pape HC; Lesch KP
    Transl Psychiatry; 2017 Oct; 7(10):e1246. PubMed ID: 28972592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychologic aspects of early pregnancy loss.
    Carter D; Misri S; Tomfohr L
    Clin Obstet Gynecol; 2007 Mar; 50(1):154-65. PubMed ID: 17304032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of serotonergic agonists on neuroendocrine responses of rhesus monkeys and patients with depression and anxiety disorders.
    Heninger GR; Charney DS; Price LH; Delgado P; Woods S; Goodman W
    Psychopharmacol Ser; 1989; 7():94-104. PubMed ID: 2687871
    [No Abstract]   [Full Text] [Related]  

  • 17. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients.
    Schruers K; Klaassen T; Pols H; Overbeek T; Deutz NE; Griez E
    Psychiatry Res; 2000 Apr; 93(3):179-87. PubMed ID: 10760376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder.
    Broocks A; Bandelow B; Koch K; Bartmann U; Kinkelbur J; Schweiger U; Hohagen F; Hajak G
    Neuropsychopharmacology; 2002 Aug; 27(2):270-8. PubMed ID: 12093600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.